Repeatability of retinal macular thickness measurements in healthy subjects and diabetic patients with clinically significant macular edema: Evaluation of the follow-up system of spectralis optical coherence tomography

Ophthalmologica

Volumn 233, Issue , 2015, Pages 186-191

  Fiore, Tito ^a   Lupidi, Marco ^a   Androudi, Sofia ^c,d   Giansanti, Fabrizio ^a   Fruttini, Daniela ^b   Cagini, Carlo ^a  

^a Departments of Oto Neuro Ophthalmological Surgical Sciences   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF THESSALY   (Greece)

^d NONE   (Greece)

Author keywords

Diabetic macular edema; Optical coherence tomography; Spectralis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT REPEATABILITY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; RETINA MACULA LUTEA; RETINAL THICKNESS; VISUAL ACUITY; ANATOMY AND HISTOLOGY; COMPARATIVE STUDY; COMPLICATION; DIABETIC RETINOPATHY; FOURIER ANALYSIS; LASER COAGULATION; MACULAR EDEMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OPTICAL COHERENCE TOMOGRAPHY; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; REPRODUCIBILITY; RETINA; STANDARDS;

DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FOLLOW-UP STUDIES; FOURIER ANALYSIS; HEALTHY VOLUNTEERS; HUMANS; LASER COAGULATION; MACULAR EDEMA; ORGAN SIZE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84930927548     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000380832     Document Type: Article

References (21)

1. Jaffe GJ, Caprioli J: Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 2004; 137: 156-169.
2. Otani T, Kishi S, Maruyama Y: Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999; 127: 688-693.
3. Haouchine B, Massin P, Tadayoni R, et al: Diagnosis of macular pseudoholes and lamellar macular holes by optical coherence tomography. Am J Ophthalmol 2004; 138: 732-739.
4. Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, et al: Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 2002; 43: 1588-1594.
5. Politoa A, Napolitano MC, Bandello F, et al: The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration. Ann Acad Med Singapore 2006; 35: 420-424.
6. Massin P, Vicaut E, Haouchine B, et al: Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 2001; 119: 1135-1142.
7. Polito A, Del Borrello M, Isola M, et al: Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography. Arch Ophthalmol 2005; 123: 1330-1337.
8. Danis RP, Fisher MR, Lambert E, et al: Results and repeatability of retinal thickness measurements from certification submissions. Arch Ophthalmol 2008; 126: 45-50.
9. Krzystolik MG, Strauber SF, Aiello LP, et al: Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 2007; 114: 1520-1525.
10. Wojtkowski M, Srinivasan V, Fujimoto JG, et al: Three-dimensional retinal imaging with high-speed ultra-high resolution optical coherence tomography. Ophthalmology 2005; 112: 1734-1746.
11. Alam S, Zawadzki RJ, Choi S, et al: Clinical application of rapid serial Fourier-domain optical coherence tomography for macular imaging. Ophthalmology 2006; 113: 1425-1431.
12. Hangai M, Ojima Y, Gotoh N, et al: Threedimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 2007; 114: 763-773.
13. Ojima Y, Hangai M, Sasahara M, et al: Threedimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography. Ophthalmology 2007; 114: 2197-2207.
14. Ahlers C, Michels S, Beckendorf A, et al: Three-dimensional imaging of pigment epithelial detachment in age-related macular degeneration using optical coherence tomography, retinal thickness analysis and topographic angiography. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1233-1239.
15. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985; 103: 1796-1806.
16. Browning DJ, Glassman AR, Aiello LP, et al; Diabetic Retinopathy Clinical Research Network: Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008; 115: 1366-1371, 1371.e1.
17. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
18. Comyn O, Heng LZ, Ikeji F, Bibi K, Hykin PG, Bainbridge JW, Patel PJ: Repeatability of Spectralis OCT measurements of macular thickness and volume in diabetic macular edema. Invest Ophthalmol Vis Sci 2012; 53: 7754-7759.
19. Fiore T, Androudi S, Iaccheri B, Lupidi M, Giansanti F, Fruttini D, Biondi L, Cagini C: Repeatability and reproducibility of retinal thickness measurements in diabetic patients with spectral domain optical coherence tomography. Curr Eye Res 2013; 38: 674-679.
20. Paunescu LA, Schuman JS, Prince LL, et al: Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using Stratus OCT. Invest Ophthalmol Vis Sci 2004; 45: 1716-1724.
21. Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT: Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 2008; 49: 4290-4296.